chenodeoxycholic acid has been researched along with Liver Neoplasms in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (16.67) | 18.7374 |
| 1990's | 10 (27.78) | 18.2507 |
| 2000's | 6 (16.67) | 29.6817 |
| 2010's | 8 (22.22) | 24.3611 |
| 2020's | 6 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Arias, IM; Fantappié, O; Gatmaitan, Z; Gentilini, P; Kamimoto, Y; Mazzanti, R | 1 |
| Choi, HS; Fan, Y; Jung, YS; Kim, HJ; Na, SY; Radhakrishnan, K | 1 |
| Chen, W; Ding, M; Guo, Y; Huang, M; Ji, L; Jin, X; Lin, Y; Liu, Z; Lu, L; Shen, Q; Wang, Y; Yan, W; Yao, J; Yu, S; Zheng, Y | 1 |
| Chen, H; Dai, Y; Gan, Q; Lai, L; Liao, S; Liu, F; Ou, M; Sui, W; Wang, B; Yang, M | 1 |
| Guan, L; Miao, P | 1 |
| Cai, J; Gonzalez, FJ; Sun, L | 1 |
| Ali, AA; Attia, YM; Elmazar, MM; Gibriel, AA; Hammam, OA; Kassem, DH; Tawfiq, RA | 1 |
| Chan, HL; Chan, WK; Chawla, Y; Chitturi, S; Dan, YY; Duseja, A; Fan, J; Farrell, G; Goh, KL; Hamaguchi, M; Hashimoto, E; Kim, SU; Lesmana, LA; Lin, YC; Liu, CJ; Ni, YH; Sollano, J; Wong, GL; Wong, SK; Wong, VW | 1 |
| Adinolfi, LE; Lonardo, A; Marrazzo, A; Maurantonio, M; Nascimbeni, F; Rinaldi, L | 1 |
| Kainuma, M; Makishima, M; Sano, K; Takada, I | 1 |
| Rinella, ME; Sanyal, AJ | 1 |
| Buchmann, B; Ciesek, S; Döhner, K; Manns, MP; Pinto Marques Souza de Oliveira, C; Sandmann, L; Sarrazin, C; Schlaphoff, V; Sodeik, B; Sprinzl, K; Veloso Alves Pereira, I; von Hahn, T; Vondran, F | 1 |
| Liu, H; Qi, J; Qin, C; Shao, D; Xu, M; Zhao, Q | 1 |
| Ahn, EY; Choi, YH; Hossain, MA; Kim, GY; Kim, MN; Kim, MY; Kim, ND; Lee, SW; Park, SE; Park, YC; Suh, H | 1 |
| Han, GQ; Liu, H; Qin, CK; Qin, CY; Ren, WH; Xu, HW | 1 |
| Abe, T; Egawa, S; Fukase, K; Ii, T; Katayose, Y; Motoi, F; Mutoh, M; Ohtsuka, H; Oikawa, M; Onogawa, T; Oshio, H; Rikiyama, T; Unno, M | 1 |
| Chang, KO; Kim, Y | 1 |
| Gao, M; Gong, W; He, F; Huang, G; Pan, Z; Xu, Z; Zeng, Y; Zhang, Y; Zhao, Y; Zhou, P | 1 |
| Boulias, K; Kardassis, D; Papakosta, P; Roussou, A; Talianidis, I; Zannis, VI | 1 |
| Jung, D; Kullak-Ublick, GA | 1 |
| Blevins, RA; Cui, J; de Pedro, N; Hrywna, Y; Huang, L; Lew, JL; Peláez, F; Thompson, JR; Wright, SD; Yu, J; Zhang, T; Zhao, A | 1 |
| Amuro, Y; Endo, T; Hayashi, E; Higashino, K; Kishimoto, S; Nakabayashi, H; Sato, J; Tanaka, M | 1 |
| Hirano, F; Inaba, M; Makino, I; Makino, Y; Miura, T; Okamoto, K; Tanaka, H | 1 |
| Endo, A; Honda, M; Itakura, H; Kawabe, Y; Kodama, T; Matsumoto, A; Shimokawa, T; Wada, Y; Yazaki, Y | 1 |
| Cooper, AD; Craig, WY; Everson, GT; Taniguchi, T | 1 |
| Hirano, F; Makino, I; Tanaka, H | 1 |
| Farrants, AK; Nilsson, A; Pedersen, JI | 1 |
| Hirano, F; Makino, I; Makino, Y; Okamoto, K; Tanaka, H | 1 |
| Kato, Y; Khan, KN; Nagataki, S; Nakao, K; Nakata, K; Tsutsumi, T | 1 |
| Calmus, Y; Conti, F; Meier, PJ; Podevin, P; Poupon, R; Rosmorduc, O | 1 |
| Eisenburg, J | 1 |
| Demers, LM; Hepner, GW | 1 |
| Axelson, M; Everson, GT; Mörk, B | 1 |
| Budai, K; Javitt, NB | 1 |
| Everson, GT; Polokoff, MA | 1 |
| Makino, I; Mashimo, K; Nakagawa, S; Shinozaki, K | 1 |
5 review(s) available for chenodeoxycholic acid and Liver Neoplasms
| Article | Year |
|---|---|
Systematic review and meta-analysis of randomized controlled trials on the effects of obeticholic acid on the blood lipid profile: Insights into liver disorders and liver cancer.
Topics: Chenodeoxycholic Acid; Humans; Lipids; Lipoproteins; Liver Diseases; Liver Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.
Topics: Animals; Antineoplastic Agents; Bile Acids and Salts; Biomarkers; Chenodeoxycholic Acid; Gastrointestinal Agents; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Metabolic Diseases; Mice; Receptors, Cytoplasmic and Nuclear; Signal Transduction | 2021 |
The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.
Topics: Adolescent; Asia; Bariatric Surgery; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Child; Diet; Exercise; Fatty Acids, Omega-3; Gastroenterology; Humans; Liver Neoplasms; Liver Transplantation; Non-alcoholic Fatty Liver Disease; Obesity; Pacific Islands; Practice Guidelines as Topic; Risk; Systematic Reviews as Topic; Thiazolidinediones; Vitamin E | 2018 |
Nonalcoholic fatty liver disease: Evolving paradigms.
Topics: Biomarkers; Chenodeoxycholic Acid; Diabetes Mellitus, Type 2; Diagnostic Imaging; Diet, Reducing; Dyslipidemias; Exercise Therapy; Humans; Hyperuricemia; Hypoglycemic Agents; Liver; Liver Function Tests; Liver Neoplasms; Mass Screening; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Prevalence; Risk Assessment; Risk Factors; Vitamin E | 2017 |
NAFLD in 2014: Genetics, diagnostics and therapeutic advances in NAFLD.
Topics: Anticholesteremic Agents; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Genetic Predisposition to Disease; Humans; Liver Neoplasms; Membrane Proteins; Non-alcoholic Fatty Liver Disease | 2015 |
31 other study(ies) available for chenodeoxycholic acid and Liver Neoplasms
| Article | Year |
|---|---|
Bile acid inhibition of P-glycoprotein-mediated transport in multidrug-resistant cells and rat liver canalicular membrane vesicles.
Topics: Animals; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile Acids and Salts; Bile Canaliculi; Biological Transport; Carcinoma, Hepatocellular; Carrier Proteins; Cell Membrane; Daunorubicin; Depression, Chemical; Doxorubicin; Drug Resistance; Liver Neoplasms; Male; Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Rhodamine 123; Rhodamines; Tumor Cells, Cultured | 1994 |
Chenodeoxycholic acid regulates fibroblast growth factor 23 gene expression via estrogen-related receptor γ in human hepatoma Huh7 cells.
Topics: Bile Acids and Salts; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Drug Inverse Agonism; Estrogens; Fibroblast Growth Factor-23; Gene Expression; Humans; Liver Neoplasms; RNA, Messenger | 2023 |
Bile acids promote the development of HCC by activating inflammasome.
Topics: Animals; Bile Acids and Salts; Carcinoma, Hepatocellular; Cells, Cultured; Chenodeoxycholic Acid; Inflammasomes; Inflammation; Liver Neoplasms; Mice; Molecular Docking Simulation; Reactive Oxygen Species | 2023 |
Dynamic Metabolomics Study of the Bile Acid Pathway During Perioperative Primary Hepatic Carcinoma Following Liver Transplantation.
Topics: Adult; Bile Acids and Salts; Biomarkers; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Chromatography, Liquid; Female; Glycocholic Acid; Graft Survival; Humans; Liver; Liver Neoplasms; Liver Transplantation; Male; Metabolomics; Middle Aged; Tandem Mass Spectrometry; Taurochenodeoxycholic Acid; Taurocholic Acid; Treatment Outcome | 2020 |
Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model.
Topics: Animals; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Janus Kinase 2; Liver Neoplasms; Male; Mice; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein | 2021 |
Farnesoid X Receptor Activation Enhances Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
Topics: Bile Acids and Salts; Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; Chenodeoxycholic Acid; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Isoxazoles; Liver; Liver Neoplasms; Receptors, Cytoplasmic and Nuclear; Transforming Growth Factor beta1 | 2018 |
Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).
Topics: Adult; Bile Acids and Salts; Carcinoma, Hepatocellular; Cell Line, Tumor; Chenodeoxycholic Acid; Coinfection; Extracellular Space; Female; Gene Expression Regulation, Neoplastic; Hepatitis B, Chronic; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Liver Neoplasms; Male; Middle Aged; Organic Anion Transporters, Sodium-Dependent; Sodium; Symporters; Virus Internalization; Virus Replication | 2015 |
Chenodeoxycholic Acid Derivative HS-1200 Inhibits Hepatocarcinogenesis and Improves Liver Function in Diethylnitrosamine-Exposed Rats by Downregulating MTH1.
Topics: Administration, Oral; Animals; Body Weight; Cell Proliferation; Chenodeoxycholic Acid; Diethylnitrosamine; DNA Repair; DNA Repair Enzymes; Down-Regulation; Gene Expression Regulation; Kidney; Liver; Liver Neoplasms; Male; Organ Size; Phosphoric Monoester Hydrolases; Pyrophosphatases; Random Allocation; Rats; Rats, Wistar; RNA, Messenger | 2017 |
A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chenodeoxycholic Acid; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclooxygenase 2; Early Growth Response Protein 1; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Tumor Suppressor Protein p53 | 2008 |
Synthetic chenodeoxycholic acid derivative, HS-1200, induces apoptosis of human hepatoma cells via a mitochondrial pathway.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 8; Caspase 9; Caspase Inhibitors; Cell Proliferation; Chenodeoxycholic Acid; Cysteine Proteinase Inhibitors; Cytochromes c; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2 | 2008 |
Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; Chenodeoxycholic Acid; Cholangiocarcinoma; Down-Regulation; Female; Gastrointestinal Agents; Humans; Lithocholic Acid; Liver Neoplasms; Male; Neoplasm Invasiveness; Snail Family Transcription Factors; Transcription Factors | 2008 |
Inhibitory effects of bile acids and synthetic farnesoid X receptor agonists on rotavirus replication.
Topics: Animals; Blotting, Western; Caco-2 Cells; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Female; Gastrointestinal Agents; Humans; Isoxazoles; Liver Neoplasms; Mice; Mice, Inbred BALB C; Real-Time Polymerase Chain Reaction; RNA-Binding Proteins; RNA, Messenger; Rotavirus; Rotavirus Infections; Triglycerides; Tumor Cells, Cultured; Virus Replication | 2011 |
FXR ligands protect against hepatocellular inflammation via SOCS3 induction.
Topics: Animals; Carcinoma, Hepatocellular; Cells, Cultured; Chenodeoxycholic Acid; Hep G2 Cells; Humans; Inflammation; Ligands; Lipopolysaccharides; Liver Neoplasms; Mice; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins | 2012 |
Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids.
Topics: Alitretinoin; Animals; Antineoplastic Agents; Apolipoprotein C-II; Apolipoproteins C; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Blotting, Western; Chenodeoxycholic Acid; Chloramphenicol O-Acetyltransferase; Chlorocebus aethiops; COS Cells; Dimerization; DNA Primers; DNA-Binding Proteins; Drug Synergism; Electrophoretic Mobility Shift Assay; Gastrointestinal Agents; Gene Expression Regulation; Hepatocyte Nuclear Factor 4; Humans; Liver Neoplasms; Luciferases; Phosphoproteins; Plasmids; Promoter Regions, Genetic; Receptors, Retinoic Acid; Receptors, Thyroid Hormone; Regulatory Sequences, Nucleic Acid; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Deletion; Thyroid Hormone Receptors beta; Transcription Factors; Transcriptional Activation; Tretinoin | 2003 |
Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression.
Topics: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Bile Acids and Salts; Carcinoma, Hepatocellular; Cell Nucleus; Chenodeoxycholic Acid; DNA-Binding Proteins; Gene Expression Regulation; Hepatocyte Nuclear Factor 1; Hepatocyte Nuclear Factor 1-alpha; Hepatocyte Nuclear Factor 1-beta; Hepatocyte Nuclear Factor 4; Humans; Liver Neoplasms; Liver-Specific Organic Anion Transporter 1; Mutagenesis; Nuclear Proteins; Phosphoproteins; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Response Elements; Transcription Factors; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 2003 |
Human kininogen gene is transactivated by the farnesoid X receptor.
Topics: Binding Sites; Blotting, Northern; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; DNA; DNA-Binding Proteins; Gene Deletion; Gene Expression Regulation; Hepatocytes; Humans; Isoxazoles; Kininogens; Liver Neoplasms; Mutagenesis, Site-Directed; Polymerase Chain Reaction; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Repetitive Sequences, Nucleic Acid; Retinoid X Receptors; RNA, Messenger; Transcription Factors; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 2003 |
Bile acid synthesis by long-term cultured cell line established from human hepatoblastoma.
Topics: Animals; Bile Acids and Salts; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; Chenodeoxycholic Acid; Chromatography, Gas; Deoxycholic Acid; Humans; Liver Neoplasms; Rats; Time Factors | 1982 |
Regulation of the major histocompatibility complex class I mRNA expression by bile acids in cultured human hepatoma cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Bile Acids and Salts; Carcinoma, Hepatocellular; Cell Line; Cell Membrane; Chenodeoxycholic Acid; Cytosol; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genes, MHC Class I; Histocompatibility Antigens Class I; Humans; Isoquinolines; Kinetics; Liver Neoplasms; Piperazines; Protein Kinase C; RNA, Messenger; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1995 |
The molecular mechanism of the induction of the low density lipoprotein receptor by chenodeoxycholic acid in cultured human cells.
Topics: Alkyl and Aryl Transferases; Base Sequence; Cell Line; Chenodeoxycholic Acid; Codon; DNA-Binding Proteins; Farnesyl-Diphosphate Farnesyltransferase; Gene Expression; Geranyltranstransferase; Hepatoblastoma; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Synthase; Leupeptins; Liver Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Protease Inhibitors; Receptors, LDL; Regulatory Sequences, Nucleic Acid; RNA, Messenger; Transferases; Tumor Cells, Cultured | 1995 |
Characteristics and regulation of bile salt synthesis and secretion by human hepatoma HepG2 cells.
Topics: Bile Acids and Salts; Biological Transport; Blotting, Northern; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholic Acid; Cholic Acids; Gas Chromatography-Mass Spectrometry; Humans; Hydroxycholesterols; Liver Neoplasms; Microsomes, Liver; Progesterone; RNA, Messenger; Tumor Cells, Cultured | 1994 |
Chenodeoxycholic acid-dependent induction of major histocompatibility complex class I mRNA expression in a human hepatoma cell line.
Topics: Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Gene Expression Regulation, Neoplastic; Genes, MHC Class I; Liver Cirrhosis, Biliary; Liver Neoplasms; RNA, Messenger; Tumor Cells, Cultured | 1993 |
Human hepatoblastoma cells (HepG2) and rat hepatoma cells are defective in important enzyme activities in the oxidation of the C27 steroid side chain in bile acid formation.
Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestanols; Cholesterol 7-alpha-Hydroxylase; Cholic Acid; Cholic Acids; Clofibric Acid; Dexamethasone; Fatty Acids; Hepatoblastoma; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Oxidation-Reduction; Rats; Rats, Wistar; Retinoids; Tumor Cells, Cultured | 1993 |
Effects of ursodeoxycholic acid and chenodeoxycholic acid on major histocompatibility complex class I gene expression.
Topics: Blotting, Northern; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Gene Expression; Histocompatibility Antigens Class I; Humans; Liver Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Ursodeoxycholic Acid | 1996 |
Regulation of alkaline phosphatase gene expression in human hepatoma cells by bile acids.
Topics: Alkaline Phosphatase; Bile Acids and Salts; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Cholic Acid; Dose-Response Relationship, Drug; Gene Expression; Humans; Liver Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Ursodeoxycholic Acid | 1998 |
Bile acids modulate the interferon signalling pathway.
Topics: 2',5'-Oligoadenylate Synthetase; Animals; Antiviral Agents; Bile Acids and Salts; Carcinoma, Hepatocellular; Carrier Proteins; Cell Survival; Chenodeoxycholic Acid; CHO Cells; Cricetinae; DNA Fragmentation; Gene Expression Regulation; GTP-Binding Proteins; Humans; Interferon alpha-2; Interferon-alpha; Kinetics; Liver Neoplasms; Models, Biological; Myxovirus Resistance Proteins; Organic Anion Transporters, Sodium-Dependent; Promoter Regions, Genetic; Proteins; Recombinant Proteins; Signal Transduction; Symporters; Tetradecanoylphorbol Acetate; Transfection; Tumor Cells, Cultured | 1999 |
[Gastroenterology and internal medicine].
Topics: alpha-Fetoproteins; Carcinoembryonic Antigen; Chenodeoxycholic Acid; Cholelithiasis; Colonic Diseases; Dietary Fiber; Endoscopy; Food, Formulated; Gastroenterology; Gastrointestinal Hormones; Histamine H2 Antagonists; Internal Medicine; Laser Therapy; Liver Neoplasms; Medicine; Parenteral Nutrition; Specialization; Ultrasonics | 1978 |
Levels of immunoreactive glycine-conjugated bile acids in health and hepatobiliary disease.
Topics: Alcoholism; Biliary Tract Diseases; Chenodeoxycholic Acid; Cholestasis; Cholic Acids; Deoxycholic Acid; Glycocholic Acid; Hepatitis; Humans; Lithocholic Acid; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Radioimmunoassay | 1976 |
Bile acid synthesis in cultured human hepatoblastoma cells.
Topics: Bile Acids and Salts; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Cholesterol; Cholic Acid; Cholic Acids; Chromatography, Gas; Gas Chromatography-Mass Spectrometry; Humans; Liver Neoplasms; Mass Spectrometry; Methylation; Steroids; Tumor Cells, Cultured | 1991 |
Cholesterol and bile acid synthesis in Hep G2 cells. Metabolic effects of 26- and 7 alpha-hydroxycholesterol.
Topics: Bile Acids and Salts; Carcinoma, Hepatocellular; Cell Line; Chenodeoxycholic Acid; Cholesterol; Cholic Acids; Humans; Hydroxycholesterols; Liver Neoplasms | 1989 |
HepG2. A human hepatoblastoma cell line exhibiting defects in bile acid synthesis and conjugation.
Topics: Bile Acids and Salts; Carcinoma, Hepatocellular; Cell Line; Chenodeoxycholic Acid; Cholestanols; Cholic Acid; Cholic Acids; Gas Chromatography-Mass Spectrometry; Humans; Liver Neoplasms | 1986 |
Measurement of sulfated and nonsulfated bile acids in human serum and urine.
Topics: Acute Disease; Bile Acids and Salts; Carbon Radioisotopes; Chenodeoxycholic Acid; Cholic Acids; Chromatography, Gas; Chromatography, Ion Exchange; Chronic Disease; Gallbladder; Glycocholic Acid; Hepatitis; Humans; Liver Cirrhosis; Liver Neoplasms; Neoplasm Metastasis; Spectrophotometry, Infrared; Sulfuric Acids; Taurocholic Acid | 1974 |